World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

NEPHROTOXICITY ATTENUATION BY PERSEA AMERICANA’S ETHANOLIC SEED EXTRACT IN EXPERIMENTAL WISTAR RATS MODEL OF ETHYLENE GLYCOL-INDUCTION

Addy P. S.*, Erigbali P. P. and Sule O. J.

ABSTRACT

Five (5) classes with five (5) rodents each were in experimental design to study impact of Persea americana’s seed extract on induced-nephrotoxicity. First group receiving animal feed and water ad libitum served for control, Group 2, positive control receiving 0.1ml/kg b.w of ethylene glycol for 7 days, Groups 3 and 4 served as treatment groups receiving 100mg/kg and 200mg/kg extract of Persea americana (EPA), twice daily for 21 days and 0.1ml/kg ethylene glycol (EG) for 7 days with continuation of the treatment of EPA and Group 5 received a reference drug of 0.2mg/kg Folic acid and 0.3mg/kg Thiamine (twice daily) for 21 days and 0.1ml/kg EG for 7 days with continues treatment of the reference drug. Nephroprotective effects of EPA was evaluated by estimating the activities of Urea, Creatinine and levels of total protein. The effects of EPA on biomarkers of oxidative damage (lipid peroxidation) and antioxidant enzymes namely, catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx) were also measured in the kidney using homogenates of the organ. EPA and the reference drug used revealed nephroprotective action for reducing (p< 0.05) Urea with creatinine when compared to the positive control. Measures of oxidative stress bio-indicators were depleted along graded dose in EPA – administered animals. Conclusively, EPA may have proffered nephroprotection not unconnected with its antioxidative bioactivity.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR